{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:22:08Z","timestamp":1789042928785,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3227-1","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T12:46:17Z","timestamp":1530708377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults"],"prefix":"10.1186","volume":"18","author":[{"given":"Marion","family":"Dollat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lifermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Deroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Berthoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Dernis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sen\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Blaison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"De Saint-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"issue":"7898","key":"3227_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","volume":"1","author":"YE Cossart","year":"1975","unstructured":"Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11;1(7898):72\u20133.","journal-title":"Lancet"},{"issue":"5","key":"3227_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/archinte.1989.00390050111022","volume":"149","author":"AD Woolf","year":"1989","unstructured":"Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989 May;149(5):1153\u20136.","journal-title":"Arch Intern Med"},{"issue":"2","key":"3227_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0889-857X(05)70014-4","volume":"24","author":"SJ Naides","year":"1998","unstructured":"Naides SJ. Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin N Am. 1998 May;24(2):375\u2013401.","journal-title":"Rheum Dis Clin N Am"},{"issue":"4","key":"3227_CR4","first-page":"324","volume":"21","author":"P Cath\u00e9bras","year":"2000","unstructured":"Cath\u00e9bras P, Robert F, Guglielminotti C, Bonnevial L, Rousset H. [primary parvovirus B19 infection in immunocompetent adults: clinical and biological manifestations. Retrospective study of 16 patients]. Rev. Med Int. 2000 Apr;21(4):324\u20139.","journal-title":"Med Int"},{"issue":"4","key":"3227_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2169\/internalmedicine.41.295","volume":"41","author":"H Hayakawa","year":"2002","unstructured":"Hayakawa H, Tara M, Niina K, Osame M. A clinical study of adult human parvovirus B19 infection. Intern Med Tokyo Jpn. 2002 Apr;41(4):295\u20139.","journal-title":"Intern Med Tokyo Jpn"},{"issue":"1","key":"3227_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<68::AID-JMV11>3.0.CO;2-2","volume":"48","author":"JR Kerr","year":"1996","unstructured":"Kerr JR, Coyle PV, DeLeys RJ, Patterson CC. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection. J Med Virol. 1996 Jan;48(1):68\u201375.","journal-title":"J Med Virol"},{"issue":"1","key":"3227_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/s10165-010-0338-y","volume":"21","author":"H Oiwa","year":"2011","unstructured":"Oiwa H, Shimada T, Hashimoto M, Kawaguchi A, Ueda T, Sugiyama E, et al. Clinical findings in parvovirus B19 infection in 30 adult patients in Kyoto. Mod Rheumatol Jpn Rheum Assoc. 2011 Feb;21(1):24\u201331.","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"issue":"7","key":"3227_CR8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1590\/S0074-02762002000700007","volume":"97","author":"OSA de","year":"2002","unstructured":"de OSA, Camacho LAB, Pereira AC de M, Faillace TF, Setubal S, do NJP. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niter\u00f3i city area, state of Rio de Janeiro, Brazil). Mem Inst Oswaldo Cruz. 2002 Oct;97(7):965\u201370.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"3227_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.revmed.2013.04.015","volume":"35","author":"D Parra","year":"2014","unstructured":"Parra D, Mekki Y, Durieu I, Broussolle C, S\u00e8ve P. Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: a retrospective study of 26 cases. Rev Med Int. 2014 May;35(5):289\u201396.","journal-title":"Rev Med Int"},{"issue":"24","key":"3227_CR10","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2169\/internalmedicine.46.0366","volume":"46","author":"K Waza","year":"2007","unstructured":"Waza K, Inoue K, Matsumura S. Symptoms associated with parvovirus B19 infection in adults: a pilot study. Intern Med Tokyo Jpn. 2007;46(24):1975\u20138.","journal-title":"Intern Med Tokyo Jpn."},{"issue":"4","key":"3227_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3851\/IMP1563","volume":"15","author":"R Dennert","year":"2010","unstructured":"Dennert R, Velthuis S, Westermann D, Donker D, Schalla S, van Suylen R-J, et al. Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy. Antivir Ther. 2010;15(4):681\u20135.","journal-title":"Antivir Ther"},{"issue":"9107","key":"3227_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(05)60609-5","volume":"351","author":"JG Hillings\u00f8","year":"1998","unstructured":"Hillings\u00f8 JG, Jensen IP, Tom-Petersen L. Parvovirus B19 and acute hepatitis in adults. Lancet Lond Engl. 1998 Mar 28;351(9107):955\u20136.","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"3227_CR13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00415-011-5931-2","volume":"258","author":"T Lenglet","year":"2011","unstructured":"Lenglet T, Haroche J, Schnuriger A, Maisonobe T, Viala K, Michel Y, et al. Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome. J Neurol. 2011 Jul;258(7):1321\u20136.","journal-title":"J Neurol"},{"issue":"4","key":"3227_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1053\/hp.2000.6714","volume":"31","author":"CM Magro","year":"2000","unstructured":"Magro CM, Dawood MR, Crowson AN. The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol. 2000 Apr;31(4):488\u201397.","journal-title":"Hum Pathol"},{"issue":"2012","key":"3227_CR15","first-page":"e250537","volume":"2012","author":"ND Oliver","year":"2012","unstructured":"Oliver ND, Millar A, Pendleton A, Oliver ND, Millar A, Pendleton A. A case report on parvovirus B19 associated myositis. Case Rep Rheumatol. 2012 Dec 10;2012(2012):e250537.","journal-title":"Case Rep Rheumatol"},{"issue":"1","key":"3227_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/317556","volume":"32","author":"G Taylor","year":"2001","unstructured":"Taylor G, Drachenberg C, Faris-Young S. Renal involvement of human parvovirus B19 in an immunocompetent host. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001 Jan;32(1):167\u20139.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"1","key":"3227_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaad.2014.02.044","volume":"71","author":"V Mage","year":"2014","unstructured":"Mage V, Lipsker D, Barbarot S, Bessis D, Chosidow O, Del Giudice P, et al. Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults. J Am Acad Dermatol. 2014 Jul;71(1):62\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3227_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/ar1691","volume":"7","author":"DN Posnett","year":"2005","unstructured":"Posnett DN, Yarilin D. Amplification of autoimmune disease by infection. Arthritis Res Ther. 2005;7(2):74\u201384.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3227_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJM198908243210807","volume":"321","author":"G Kurtzman","year":"1989","unstructured":"Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years\u2019 duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989 Aug 24;321(8):519\u201323.","journal-title":"N Engl J Med"},{"issue":"7","key":"3227_CR20","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/cid\/cis1046","volume":"56","author":"Y Crabol","year":"2013","unstructured":"Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013 Apr;56(7):968\u201377.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"9","key":"3227_CR21","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1086\/374666","volume":"36","author":"JR Kerr","year":"2003","unstructured":"Kerr JR, Cunniffe VS, Kelleher P, Bernstein RM, Bruce IN. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome. Clin Infect Dis Off Publ Infect Dis Soc Am. 2003 May 1;36(9):e100\u20136.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"5","key":"3227_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10156-008-0636-X","volume":"14","author":"E Ogawa","year":"2008","unstructured":"Ogawa E, Otaguro S, Murata M, Kainuma M, Sawayama Y, Furusyo N, et al. Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection. J Infect Chemother Off J Jpn Soc Chemother. 2008 Oct;14(5):377\u201382.","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"issue":"19","key":"3227_CR23","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJM200105103441919","volume":"344","author":"M Viguier","year":"2001","unstructured":"Viguier M, Guillevin L, Laroche L. Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin. N Engl J Med. 2001 May 10;344(19):1481\u20132.","journal-title":"N Engl J Med"},{"issue":"3","key":"3227_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0950268899003817","volume":"124","author":"HA Kelly","year":"2000","unstructured":"Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect. 2000 Jun;124(3):449\u201357.","journal-title":"Epidemiol Infect"},{"key":"3227_CR25","doi-asserted-by":"crossref","unstructured":"Kerr JR. Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis. 1996;15(1):10\u201329.","DOI":"10.1007\/BF01586181"},{"issue":"1","key":"3227_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S1297-319X(02)00004-0","volume":"70","author":"O Meyer","year":"2003","unstructured":"Meyer O. Parvovirus B19 and autoimmune diseases. Jt Bone Spine Rev Rhum. 2003 Feb;70(1):6\u201311.","journal-title":"Jt Bone Spine Rev Rhum"},{"issue":"3","key":"3227_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/0268-960X(95)90023-3","volume":"9","author":"KE Brown","year":"1995","unstructured":"Brown KE, Young NS. Parvovirus B19 infection and hematopoiesis. Blood Rev. 1995 Sep;9(3):176\u201382.","journal-title":"Blood Rev"},{"issue":"2","key":"3227_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bjh.13421","volume":"170","author":"A Wolfromm","year":"2015","unstructured":"Wolfromm A, Rodriguez C, Michel M, Habibi A, Audard V, Benayoun E, et al. Spectrum of adult parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice. Br J Haematol. 2015 Jul;170(2):192\u20139.","journal-title":"Br J Haematol"},{"issue":"10","key":"3227_CR29","first-page":"740","volume":"25","author":"P S\u00e8ve","year":"2004","unstructured":"S\u00e8ve P, Ferry T, Charhon A, Calvet A, Broussolle C. [systemic manifestations of parvovirus B19 infections]. Rev. Med Int. 2004 Oct;25(10):740\u201351.","journal-title":"Med Int"},{"issue":"6","key":"3227_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/DAD.0b013e3181ce5933","volume":"32","author":"RR Fortna","year":"2010","unstructured":"Fortna RR, Toporcer M, Elder DE, Junkins-Hopkins JM. A case of sweet syndrome with spleen and lymph node involvement preceded by parvovirus B19 infection, and a review of the literature on extracutaneous sweet syndrome. Am J Dermatopathol. 2010 Aug;32(6):621\u20137.","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"3227_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/rmv.1782","volume":"24","author":"F Barah","year":"2014","unstructured":"Barah F, Whiteside S, Batista S, Morris J. Neurological aspects of human parvovirus B19 infection: a systematic review. Rev Med Virol. 2014 May;24(3):154\u201368.","journal-title":"Rev Med Virol"},{"issue":"6","key":"3227_CR32","first-page":"777","volume":"16","author":"CA Soloninka","year":"1989","unstructured":"Soloninka CA, Anderson MJ, Laskin CA. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol. 1989 Jun;16(6):777\u201381.","journal-title":"J Rheumatol"},{"issue":"4","key":"3227_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/ard.2004.024877","volume":"64","author":"J Hermann","year":"2005","unstructured":"Hermann J, Demel U, St\u00fcnzner D, Daghofer E, Tilz G, Graninger W. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall. Ann Rheum Dis. 2005 Apr;64(4):641\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3227_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0049-0172(99)80016-X","volume":"28","author":"S Trapani","year":"1999","unstructured":"Trapani S, Ermini M, Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum. 1999 Apr;28(5):319\u201325.","journal-title":"Semin Arthritis Rheum"},{"key":"3227_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcv.2014.11.021","volume":"62","author":"L Attard","year":"2015","unstructured":"Attard L, Bonvicini F, Gelsomino F, Manfredi R, Cascavilla A, Viale P, et al. Paradoxical response to intravenous immunoglobulin in a case of parvovirus B19-associated chronic fatigue syndrome. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2015 Jan;62:54\u20137.","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"issue":"3","key":"3227_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1086\/589863","volume":"47","author":"F Bonvicini","year":"2008","unstructured":"Bonvicini F, Marinacci G, Pajno MC, Gallinella G, Musiani M, Zerbini M. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008 Aug 1;47(3):385\u20137.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"2","key":"3227_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3851\/IMP1516","volume":"15","author":"R Dennert","year":"2010","unstructured":"Dennert R, Velthuis S, Schalla S, Eurlings L, van Suylen R-J, van Paassen P, et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther. 2010;15(2):193\u2013201.","journal-title":"Antivir Ther"},{"issue":"4","key":"3227_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s100670200080","volume":"21","author":"MP Guillaume","year":"2002","unstructured":"Guillaume MP, Hermanus N, Peretz A. Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection. Clin Rheumatol. 2002 Aug;21(4):306\u20138.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"3227_CR39","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1086\/432118","volume":"41","author":"SM Lowry","year":"2005","unstructured":"Lowry SM, Brent LH, Menaldino S, Kerr JR. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005 Aug 15;41(4):e42\u20134.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"key":"3227_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/1471-2334-10-246","volume":"10","author":"TH Mogensen","year":"2010","unstructured":"Mogensen TH, Jensen JMB, Hamilton-Dutoit S, Larsen CS. Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis. 2010;10:246.","journal-title":"BMC Infect Dis"},{"issue":"9487","key":"3227_CR41","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0140-6736(05)67184-X","volume":"366","author":"Y Munakata","year":"2005","unstructured":"Munakata Y, Kodera T, Saito T, Sasaki T. Rheumatoid arthritis, type 1 diabetes, and graves\u2019 disease after acute parvovirus B19 infection. Lancet. 2005 Sep 27;366(9487):780.","journal-title":"Lancet"},{"issue":"5","key":"3227_CR42","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1128\/JCM.00706-08","volume":"47","author":"L Pironi","year":"2009","unstructured":"Pironi L, Bonvicini F, Gionchetti P, D\u2019Errico A, Rizzello F, Corsini C, et al. Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease. J Clin Microbiol. 2009 May;47(5):1591\u20135.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3227_CR43","first-page":"515","volume":"18","author":"HD Stahl","year":"2000","unstructured":"Stahl HD, Pfeiffer R, Emmrich F. Intravenous treatment with immunoglobulins may improve chronic undifferentiated mono- and oligoarthritis. Clin Exp Rheumatol. 2000 Aug;18(4):515\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"3227_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.antiviral.2014.11.004","volume":"113","author":"F Bonvicini","year":"2015","unstructured":"Bonvicini F, Bua G, Manaresi E, Gallinella G. Antiviral effect of cidofovir on parvovirus B19 replication. Antivir Res. 2015 Jan;113:11\u20138.","journal-title":"Antivir Res"},{"issue":"7","key":"3227_CR45","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1086\/651164","volume":"50","author":"L Chiche","year":"2010","unstructured":"Chiche L, Grados A, Harl\u00e9 J-R, Cacoub P. Mixed cryoglobulinemia: a role for parvovirus b19 infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010 Apr 1;50(7):1074\u20135.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3227-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3227-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3227-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T23:05:37Z","timestamp":1562195137000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3227-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3227"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3227-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in compliance with the protocol of Good Clinical Practices and Declaration of Helsinki principles. In accordance with French law (Loi de Sant\u00e9 publique 2004 - Loi n\u00b0 2004\u2013806 du 9 ao\u00fbt 2004), the need for consent was deemed unnecessary and formal approval from an ethical committee was not required for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"302"}}